Log-In
|
Home
|
E-mail Alerts
|
My Headlines
|
Portfolio
Upgrade to StreetInsider Premium - FREE TRIAL!
Join Free
SI Premium
Full Feed View
Headline View
Upgrade to SI Premium
Ratings Insider
Analyst Comments
Hot Analyst Comments $
Analyst EPS Change
Analyst EPS View
Analyst PT Change
Credit Ratings
Downgrade News
Hot Downgrades $
New Coverage News
Hot New Coverage $
Upgrade News
Hot Upgrades $
More...
M&A Insider
Merger News $
Hot M&A News $
Private Equity
Rumors $
Merger Arbitrage
2013's Top M&A Deals
Top 50 Takeover Targets
More...
EPS Insider
Earnings Calendar
Earnings News
Hot Earnings $
Guidance
Hot Guidance $
Conference Calls
Earnings History Search
More...
Dividend Insider
Dividend News
Special Dividends $
Stock Buybacks
Hot Stock Buybacks $
Stock Splits
More...
IPO Insider
IPO News
Recent IPOs
Upcoming IPOs
More...
Hedge Fund Insider
Hedge Funds News
More...
Partners
QUICK LINKS :
Upcoming Dividends
EPS Movers
Top Upgrades
Buffett's Stocks
*NEW SI App
Newsletters
Follow @Street_Insider
More on SRPT
- Summary
- Chart
- Profile
- Historical
Data
- Earnings
- Ratings
- Holders
News
- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...
- 13Ds
- 13Fs
- 13Gs
- Analyst Comments
- Analyst EPS Change
- Analyst EPS View
- Analyst PT Change
- Commodities
- Conference Calls
- Contributors
- Corporate News
- Credit Ratings
- Dividends
- Downgrades
- Earnings
- Economic Data
- Equity Offerings
- ETFs
- FDA
- Fed
- Forex
- General News
- Hedge Funds
- Hot Buybacks
- Hot Comments
- Hot Corp. News
- Hot Dividends
- Hot Downgrades
- Hot Earnings
- Hot FDA News
- Hot Guidance
- Hot Hedge Fund News
- Hot Insider Trades
- Hot IPOs
- Hot List
- Hot M&A
- Hot Mgmt Changes
- Hot New Coverage
- Hot Upgrades
- Insiders' Blog
- IPOs
- Life Enjoyed
- Litigation
- Management Comments
- Market Check
- Momentum Movers
- New Coverage
- Option EPS Action
- Options
- Press Releases
- Private Equity
- SEC Filings
- Special Dividends
- Special Reports
- Stock Splits
- Technicals
- Trader Talk
- Trading Halts
- Upgrades
SAREPTA THERAP (NQ:SRPT)
Delayed:
38.15
+0.39 (1.03%)
Trade Now!
Previous Close
$37.76
52 Week High
$45.00
Open
$37.70
52 Week Low
$3.30
Day High
$38.46
P/E
N/A
Day Low
$36.95
EPS
$-5.67
Volume
857,132
Friends, Peers and Foes
(?)
:
GSK
,
S
,
MRIN
,
NTSC
,
OMTH
(more...)
ALERTS
|
RSS
All Recent
SI Reports
Press Releases
SEC Filings
Major News
Jun 18, 2013 04:52 PM
Form 4 Sarepta Therapeutics, For: Jun 14 Filed by: CHASE ANTHONY R
Jun 17, 2013 12:21 PM
Preliminary Russell 3000 Addition Pushing Stocks Around
Jun 7, 2013 06:02 AM
Form 4 Sarepta Therapeutics, For: Jun 04 Filed by: Aphale Jayant
Jun 7, 2013 06:02 AM
Form 4 Sarepta Therapeutics, For: Jun 04 Filed by: Martignetti Anthony
Jun 7, 2013 06:02 AM
Form 4 Sarepta Therapeutics, For: Jun 04 Filed by: Howton David T
Jun 7, 2013 06:02 AM
Form 4 Sarepta Therapeutics, For: Jun 04 Filed by: Mahatme Sandesh
Jun 7, 2013 06:02 AM
Form 4 Sarepta Therapeutics, For: Jun 04 Filed by: Christopher Nishan Garabedian
Jun 6, 2013 10:00 PM
Form 4 Sarepta Therapeutics, For: Jun 04 Filed by: HODGMAN JOHN
Jun 6, 2013 09:59 PM
Form 4 Sarepta Therapeutics, For: Jun 04 Filed by: Kaye Edward M. MD
Jun 6, 2013 09:56 PM
Form 4 Sarepta Therapeutics, For: Jun 04 Filed by: Goolsbee William Alden
View All Articles
May 9, 2013 07:48 AM
Sarepta Therap (SRPT) Tops Q1 EPS by 21c
Oct 3, 2012 07:12 AM
Sarepta Therapeutics (SRPT) Surges as Eteplirsen Met the Primary Endpoint
Jul 24, 2012 08:08 AM
Sarepta Therapeutics (SRPT) More Than Doubles on Strong Trial Results
Jul 24, 2012 07:16 AM
Sarepta Therapeutics (SRPT) Reports Statistically Significant Data for Eteplirsen in DMD Patients
Jun 17, 2013 12:21 PM
Preliminary Russell 3000 Addition Pushing Stocks Around
May 30, 2013 03:53 PM
Wedbush Says Sarepta (SRPT) May File for Accelerated Approval in H1 2014
May 30, 2013 03:19 PM
Sarepta (SRPT) Moves Lower on Unconfirmed Chatter
May 28, 2013 03:58 PM
Sarepta Therapeutic's (SRPT) Eteplirsen Could Have Safety Advantage
May 13, 2013 12:28 PM
Big Potential, Yet Hurdles Remain for Sarepta Therapeutic (SRPT) - Burrill
May 9, 2013 07:48 AM
Sarepta Therap (SRPT) Tops Q1 EPS by 21c
May 8, 2013 03:07 PM
Trading Radar for 05/09: priceline.com (PCLN), NVIDIA (NVDA), DISH Network (DISH), Dean Foods (DF) Report
Apr 22, 2013 10:50 AM
Notable Analyst Rating Changes 04/22: (AAPL) (HES) (FNFG) Upgraded; (GE) (MCD) (NEM) Downgraded
Apr 22, 2013 09:40 AM
StreetInsider.com Pre-Open Movers 4/22: (PWER) (MPR) (MSFT) Higher; (AFSI) (WIT) (PHG) Lower (more...)
Apr 22, 2013 08:10 AM
Needham & Company Starts Sarepta Therapeutic (SRPT) at Buy
View All Reports
Jun 5, 2013 08:30 AM
Sarepta Therapeutics to Present Company Overview at the Wells Fargo Securities 2013 Healthcare Conference
May 10, 2013 08:30 AM
Sarepta Therapeutics to Present Company Overview at Upcoming Conferences
May 9, 2013 07:00 AM
Sarepta Therapeutics Announces First Quarter 2013 Financial Results and Recent Corporate Developments
May 7, 2013 08:30 AM
Sarepta Therapeutics Initiates Dosing in Phase I Multiple Ascending Dose Study of Drug for Treatment of Marburg Virus
Apr 26, 2013 04:05 PM
Sarepta Therapeutics to Announce First Quarter 2013 Financial Results and Corporate Update on May 9, 2013
View All Press Releases
Jun 18, 2013 04:52 PM
Form 4 Sarepta Therapeutics, For: Jun 14 Filed by: CHASE ANTHONY R
Jun 7, 2013 06:02 AM
Form 4 Sarepta Therapeutics, For: Jun 04 Filed by: Howton David T
Jun 7, 2013 06:02 AM
Form 4 Sarepta Therapeutics, For: Jun 04 Filed by: Martignetti Anthony
Jun 7, 2013 06:02 AM
Form 4 Sarepta Therapeutics, For: Jun 04 Filed by: Aphale Jayant
Jun 7, 2013 06:02 AM
Form 4 Sarepta Therapeutics, For: Jun 04 Filed by: Mahatme Sandesh
Jun 7, 2013 06:02 AM
Form 4 Sarepta Therapeutics, For: Jun 04 Filed by: Christopher Nishan Garabedian
Jun 6, 2013 10:00 PM
Form 4 Sarepta Therapeutics, For: Jun 04 Filed by: HODGMAN JOHN
Jun 6, 2013 09:59 PM
Form 4 Sarepta Therapeutics, For: Jun 04 Filed by: Kaye Edward M. MD
Jun 6, 2013 09:56 PM
Form 4 Sarepta Therapeutics, For: Jun 04 Filed by: Goolsbee William Alden
Jun 6, 2013 09:55 PM
Form 4 Sarepta Therapeutics, For: Jun 04 Filed by: CHASE ANTHONY R
View All Filings
Entities mentioned with
SRPT
Earnings
|
View Related Stories »
Deutsche Bank
|
View Related Stories »
Needham & Company
|
View Related Stories »
Citi
|
View Related Stories »
Bank of America
|
View Related Stories »
JPMorgan
|
View Related Stories »
UBS
|
View Related Stories »
Unusual 11 Mid-Day Movers
|
View Related Stories »
Lazard
|
View Related Stories »
Credit Suisse
|
View Related Stories »
Twitter
|
View Related Stories »
Dividend
|
View Related Stories »
Stifel Nicolaus
|
View Related Stories »
After-Hours Movers
|
View Related Stories »
Barron's
|
View Related Stories »
Barclays
|
View Related Stories »
Stock Buyback
|
View Related Stories »
Dollar Thrifty Takeover
|
View Related Stories »
Notable Analyst Rating Changes
|
View Related Stories »
Merrill Lynch
|
View Related Stories »
ThinkEquity
|
View Related Stories »
Jefferies & Co
|
View Related Stories »
JMP Securities
|
View Related Stories »
Canaccord Genuity
|
View Related Stories »
Piper Jaffray
|
View Related Stories »
Show More...
View All Entities